HA/GSA-Rmax ratio as a predictor of postoperative liver failure

World Journal of Surgery

Volumn 32, Issue 11, 2008, Pages 2410-2418

  Kaibori, Masaki ^a   Ha Kawa, Sang Kil ^a   Ishizaki, Morihiko ^a   Matsui, Kosuke ^a   Saito, Takamichi ^a   Kwon, A Hon ^a   Kamiyama, Yasuo ^a  

^a KANSAI MEDICAL UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; PENTETATE GALACTOSYL HUMAN SERUM ALBUMIN TC 99M; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DRUG ELIMINATION; FEMALE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER FUNCTION TEST; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POSTOPERATIVE COMPLICATION; PREDICTION; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SURGICAL MORTALITY; SURGICAL RISK;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; FEMALE; HEPATECTOMY; HUMANS; HYALURONIC ACID; LIVER FAILURE; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TECHNETIUM TC 99M PENTETATE;

EID: 53949089169     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-008-9725-3     Document Type: Article

References (67)

1. X Bosch J Ribes J Borras 1999 Epidemiology of primary liver cancer Semin Liver Dis 19 71 285
2. SD Taylor-Robinson GR Foster S Arora 1997 Increase in primary liver cancer in the UK 1979-94 Lancet 350 1142 1143
3. HB EI-Serag AC Mason 1999 Rising incidence of hepatocellular carcinoma in the United States N Engl J Med 340 745 750
4. ST Fan EC Lai CM Lo 1995 Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis Arch Surg 130 198 203
5. DE Nadig TP Wada RB Fairchild 1997 Major hepatic resection Arch Surg 132 115 119
6. M Shimada K Takenaka Y Fujiwara 1998 Risk factors linked to postoperative morbidity in patients with hepatocellular carcinoma Br J Surg 85 195 198
7. CN Yeh MF Chen WC Lee 2002 Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis J Surg Oncol 81 195 202
8. E Benzoni A Cojutti D Lorenzin 2007 Liver resective surgery: a multivariate analysis of postoperative outcome and complication Langenbecks Arch Surg 392 45 54
9. S Balzan J Belghiti O Farges 2005 The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy Ann Surg 242 824 829
10. O Farges B Malassagne JF Fleijou 1999 Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal Ann Surg 229 210 215
11. S Miyazaki K Takasaki M Yamamoto 1999 Liver regeneration and restoration of liver function after partial hepatectomy: the relation of fibrosis of the liver parenchyma Hepatogastroenterology 46 2919 2924
12. H Tanaka K Hirohashi S Kubo 1999 Influence of histological inflammatory activity on regenerative capacity of liver after percutaneous transhepatic portal vein embolization J Gastroenterol 34 100 104
13. N Nagasue H Kohno M Tachibana 1999 Prognostic factors after hepatic resection for hepatocellular carcinoma associated with Child-Turcotte class B and C cirrhosis Ann Surg 229 84 90
14. H Eguchi K Umeshita M Sakon 2000 Presence of active hepatitis associated with liver cirrhosis is a risk factor for mortality caused by posthepatectomy liver failure Dig Dis Sci 45 1383 1388
15. BC Das S Isaji Y Kawarada 2001 Analysis of 100 consecutive hepatectomies: risk factors in patients with liver cirrhosis or obstructive jaundice World J Surg 25 266 273
16. Y Shimahara N Yamamoto N Uyama 2002 Significance of serum type IV collagen level of hepatectomized patients with chronic liver damage World J Surg 26 451 456
17. S Kubo T Tsukamoto K Hirohashi 2003 Appropriate surgical management of small hepatocellular carcinomas in patients infected with hepatitis C virus World J Surg 27 437 442
18. S Yachida H Wakabayashi Y Kokudo 2000 Measurement of serum hyaluronate as a predictor of human liver failure after major hepatectomy World J Surg 24 359 364
19. T Mizuguchi T Katsuramaki T Nobuoka 2004 Serum hyaluronate level for predicting subclinical liver dysfunction after hepatectomy World J Surg 28 971 976
20. JB Burgess JU Baenziger WR Brown 1992 Abnormal surface distribution of the human asialoglycoprotein receptor in cirrhosis Hepatology 15 702 706
21. SK Ha-Kawa Y Tanaka S Hasebe 1997 Compartmental analysis of asialoglycoprotein receptor scintigraphy for quantitative measurement of liver function: a multicentre study Eur J Nucl Med 24 130 137
22. AH Kwon SK Ha-Kawa S Uetsuji 1995 Use of technetium 99m diethylenetriaminepentaacetic acid-galactosyl-human serum albumin liver scintigraphy in the evaluation of preoperative and postoperative hepatic functional reserve for hepatectomy Surgery 117 429 434
23. M Kudo A Todo K Ikekubo 1991 Functional hepatic imaging with receptor-binding radiopharmaceutical: clinical potential as a measure of functioning hepatocyte mass Gastroenterol Jpn 26 734 741
24. 99mTc-GSA) liver scintigraphy Hepatology 25 426 429
25. SM Strasberg J Belghiti P-A Clavn 2000 The Brisbane 2000 terminology of liver anatomy and resection: Terminology Committee of the International Hepato-Pancreato-Biliary Association HPB 2 333 339
26. Couinaud C (1957) Les hepatectomies elargies. In: Couinaud C (ed) Le Foie: Etudes Anatomiques et Chirurgicales. Masson, Paris, pp 400-409
27. T Suou S Yamada K Hosho 1996 Relationship between serum and hepatic 7s fragments of type IV collagen in chronic liver disease Hepatology 23 1154 1158
28. K Horii S Kubo K Hirohashi 1999 Changes in erythrocyte deformability after liver resection for hepatocellular carcinoma associated with chronic liver disease World J Surg 25 85 90
29. Sobin LH, Wittekind C (eds) (1997) TNM classification of malignant tumours, 5th edn. Wiley, New York
30. J Figueras E Jaurrieta C Valls 2000 Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy J Am Coll Surg 190 580 587
31. J Michel B Suc F Montpeyroux 1997 Liver resection or transplantation for hepatocellular carcinoma? Retrospective analysis of 215 patients with cirrhosis J Hepatol 26 1274 1280
32. FP Sarasin E Giostra G Mentha 1998 Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost-effectiveness perspective Hepatology 28 436 442
33. V Mazzaferro E Regalia R Doci 1996 Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 693 699
34. R Adam D Azoulay D Castaing 2003 Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Ann Surg 238 508 519
35. AS Befeler AM Di Bisceglie 2002 Hepatocellular carcinoma: diagnostics and treatment Gastroenterology 122 1609 1619
36. H Bismuth PE Majno R Adam 1999 Liver transplantation for hepatocellular carcinoma Semin Liver Dis 19 311 322
37. RN Pugh IM Murray-Lyon JL Dawson 1973 Transection of the oesophagus for bleeding oesophageal varices Br J Surg 60 646 649
38. N Yamanaka E Okamoto T Oriyama 1994 A prediction scoring system to select the surgical treatment of liver cancer: further refinement based on 10 years of use Ann Surg 219 342 346
39. B Smedsrod H Pertoft S Eriksson 1984 Studies in vitro on the uptake and degradation of sodium hyaluronate in rat liver endothelial cells Biochem J 223 617 626
40. AM Gressner S Schafer 1989 Comparison of sulphated glycosaminoglycan and hyaluronate synthesis and secretion in cultured hepatocytes, fat storing cells, and Kupffer cells J Clin Chem 27 141 149
41. JR Fraser TC Laurent A Engstrom-Laurent 1984 Elimination of hyaluronic acid from the blood stream in the human Clin Exp Pharmacol Physiol 11 17 25
42. H Shimizu W He P Guo 1994 Serum hyaluronate in the assessment of liver endotherial cell function after orthotopic liver transplantation in the rat Hepatology 20 1323 1329
43. L Paimela A Heiskanen P Kurki 1991 Serum hyaluronate level as a predictor of radiologic progression in early rheumatoid arthritis Arthritis Rheum 34 815 821
44. A Engstrom-Laurent N Feltelius R Hallgren 1985 Raised serum hyaluronate levels in scleroderma: an effect of growth factor induced activation of connective tissue cells? Ann Rheum Dis 44 614 620
45. 3H] hyaluronan injected subcutaneously in rabbits Am J Physiol 259 H532 H535
46. Y Murawaki Y Ikuta M Koda 1996 Clinical significance of serum hyaluronan in patients with chronic viral liver disease J Gastroenterol Hepatol 11 459 465
47. VS Wong V Hughes A Trull 1998 Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection J Viral Hepatol 5 187 192
48. T Ninomiya S Yoon Y Hayashi 1998 Clinical significance of serum hyaluronic acid as a fibrosis marker in chronic hepatitis C patients treated with interferon-alpha: histological evaluation by a modified histological activity index scoring system J Gastroenterol Hepatol 13 68 74
49. Y Murawaki Y Ikuta K Okamoto 2001 Diagnostic value of serum markers of connective tissue turnover for predicting histological staging and grading in patients with chronic hepatitis C J Gastroenterol 36 399 406
50. CC Wu WL Ho DC Yeh 1996 Hepatic resection of hepatocellular carcinoma in cirrhotic livers: is it unjustified in impaired liver function? Surgery 120 34 39
51. M Shimada T Matsumata K Akazawa 1994 Estimation of risk of major complications after hepatic resection Am J Surg 167 399 403
52. N Nagasue H Yukaya Y Ogawa 1987 Human liver regeneration after major hepatic resection: a study of normal liver and livers with chronic hepatitis and cirrhosis Ann Surg 206 30 39
53. K Takenaka T Kanematsu K Fukuzawa 1990 Can hepatic failure after surgery for hepatocellular carcinoma in cirrhotic patients be prevented? World J Surg 14 123 127
54. MR Kilbourn MR Zalutsky 1985 Research and clinical potential of receptor based radiopharmaceuticals J Nucl Med 26 655 662
55. Stadalnik RC, Vera DR, Krohn KA (1986) Receptor-binding radiopharmaceuticals: experimental and clinical aspects. In: Freemann LM, Weissmann HS (eds) Nuclear medicine annual 1986. Raven, New York, pp 105-139
56. DR Vera RC Stadalnik KA Krohn 1985 Technetium-99 m galactosyl- neoglycoalbumin: preparation and preclinical studies J Nucl Med 26 1157 1167
57. 99mTc-DTPA-asialo-orosomucoid. II. Human dynamic and imaging studies J Nucl Med Allied Sci 32 117 126
58. U Gartner RJ Stockert AG Morell 1981 Modulation of the transport of bilirubin and asialoorosomucoid during liver regeneration Hepatology 1 99 106
59. B Meyer HS Luo M Bargetzi 1991 Quantitation of intrinsic drug-metabolizing capacity in human liver biopsy specimens: support for the intact-hepatocyte theory Hepatology 13 475 481
60. G Ashwell AG Morell 1974 The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins Adv Enzymol Relat Areas Mol Biol 41 99 128
61. RJ Stockert AG Morell 1983 Hepatic binding protein: the galactose-specific receptor of mammalian hepatocytes Hepatology 3 750 757
62. T Kanematsu K Takenaka T Matsumata 1984 Limited hepatic resection effective for selected cirrhotic patients with primary liver cancer Ann Surg 199 51 56
63. A Castells J Bruix C Bru 1993 Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection Hepatology 18 1121 1126
64. T Livraghi L Bolondi S Lazzaroni 1992 Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis: a study on 207 patients Cancer 69 925 929
65. T Seki M Wakabayashi T Nakagawa 1994 Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma Cancer 74 817 825
66. S Rossi E Buscarini F Garbagnati 1998 Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode Am J Roentgenol AJR 170 1015 1022
67. L Buscarini E Buscarini M Di Stasi 2001 Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results Eur Radiol 11 914 921